DNA registry for germ cell and testicular tumors
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study collects DNA and medical information to better understand germ cell and testicular tumors and possible inherited genetic causes. It may help researchers sort out how genetic changes relate to these cancers, even if you’re not receiving a new drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to speak/read English.
- If you’re enrolling as a patient: you must have a germ cell tumor or a testicular mass (or strong suspicion).
- If you’re enrolling as a family member: you must be a blood relative of the main patient (the “proband”).
- If you’re enrolling as a control person: you must not have had cancer (except non-melanoma skin cancer) and must not have a close family history of germ cell or testicular tumors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at “molecular” (DNA-related) features of germ cell tumors in children and teens. It also follows patients over time, which can help researchers understand tumor patterns and improve future care.
This study collects DNA from adults with kidney cancer (or suspected kidney cancer), plus DNA from some family members and healthy controls. It helps researchers understand whether certain genetic changes might be linked to kidney cancer risk.
This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.
This study looks at DNA (genetic information) from people and families who may have an inherited risk for cancer. It aims to find new genetic markers that can help explain cancer risk and guide future care.
This trial looks for signs of cancer DNA in your blood (circulating tumor DNA) to see if it can help track germ cell tumors. It may help doctors find out if your cancer is coming back earlier.
This study looks for inherited gene changes in men with testicular cancer and their close family members. Understanding these genes may help explain why some families have a higher risk.
Hear when a new Germ Cell Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.